image
Viridian Therapeutics, Inc. VRDN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 20.14
-6.93 %
$ 1.6 B
Market Cap
-4.66
P/E
BALANCE SHEET
490 M ASSETS
12.72%
Growth Rates
1Year 12.72%
3Years 55.17%
5Years 49.28%
7Years 97.00%
10Years 63.14%
48.4 M LIABILITIES
20.92%
Growth Rates
1Year 20.92%
3Years 62.80%
5Years 26.74%
7Years 40.03%
10Years 40.23%
442 M EQUITY
11.89%
Growth Rates
1Year 11.89%
3Years 54.42%
5Years 53.81%
7Years 180.25%
10Years 71.34%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Viridian Therapeutics, Inc.
image
Current Assets 486 M
Cash & Short-Term Investments 477 M
Receivables 102 K
Other Current Assets 9.01 M
Non-Current Assets 3.95 M
Long-Term Investments 0
PP&E 3.34 M
Other Non-Current Assets 604 K
Current Liabilities 26.6 M
Accounts Payable 2.24 M
Short-Term Debt 843 K
Other Current Liabilities 23.6 M
Non-Current Liabilities 21.8 M
Long-Term Debt 20.2 M
Other Non-Current Liabilities 1.56 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 102.8 155.6 42.3 45.9 24.8 32.6 47.4 3.3 10.8 5.1 0.2 0.1
Short Term Investments 374.5 269.0 154.7 81.7 2.0 29.9 0 0 0 0 0 0
Receivables 0.1 0.1 0.5 0 0.1 24 K 1.5 0.5 0.4 1.1 1.0 1.2
Inventory 0 (6.6) 0 0 0 0 1 64 K 0.2 0.2 0.4 0.2
Other Current Assets 9.0 6.5 2.6 2.0 5.4 5.2 4.8 0.3 0.6 0.4 0.5 0.2
Total Current Assets 486.5 424.6 200.2 129.6 29.7 65.4 51.9 4.3 11.7 6.8 2.1 1.7
PP&E 3.3 2.9 2.1 0.8 0.5 0.7 0.6 0.6 1.2 1.2 0.9 1.1
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0.6 7.6 1.5 0.9 (0.5) 50 K 50 K 0.3 15 K 90 K 0.7 45.6 K
Other Assets 0 0 0 0 0 0 0 (0.9) 0 0 0 0
Total Assets 490.4 435.1 203.7 131.3 30.3 66.1 52.5 4.3 12.9 8.1 3.7 2.8
LIABILITIES
Accounts Payable 2.2 14.2 2.3 0.7 1.1 0.6 0.9 0.2 0.2 0.3 100 K 26.7 K
Short Term Debt 0.8 0.6 0.5 0.5 4.0 2.3 0 0 1.1 80 K 0.7 22.6
Other Current Liabilities 23.3 18.2 10.5 9.2 5.1 3.9 3.0 4.4 1.1 1.7 0.5 1.0
Total Current Liabilities 26.6 33.3 13.6 10.7 10.2 6.7 3.9 4.6 2.5 2.0 1.4 23.6
Long Term Debt 20.2 4.6 0 0 4.3 8.0 9.9 2.8 0 0 0 42 K
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 1.0 1.2 1.2 0.5 0 66 K 0.2 0 24 K 0.1 0.3 0.6
Total Liabilities 48.4 40.0 16.0 11.2 14.5 14.8 14.0 4.6 2.5 2.1 1.6 24.2
EQUITY
Common Stock 0.5 0.4 0.2 42 K 0.3 0.3 0.2 7 K 0.1 38 K 27.9 K 0
Retained Earnings (725.9) (488.2) (358.3) (278.9) (168.2) (126.3) (93.6) (30.6) (18.0) (6.6) (25.9) (21.4)
Other Accumulative Comprehensive Income/Loss 0.3 (0.4) (0.2) 8 K 0 3 K (2.8) 0 (0.7) (0.6) (0.4) (0.3)
Total Equity 442.0 395.1 187.7 120.0 15.8 51.3 38.5 (0.3) 10.4 6.0 2.0 (21.4)
Total Liabilities and Equity 490.4 435.1 203.7 131.3 30.3 66.1 52.5 4.3 12.9 8.1 3.7 2.8
SHARES OUTSTANDING
Common Shares Outstanding 44.8 32.1 11.9 3.6 2.1 2.0 1.3 0.7 0.5 0.2 0.2 0.2